{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:26:16Z","timestamp":1791584776894,"version":"4.3.4"},"reference-count":159,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001409","name":"India Ministry of Science & Technology Department of Science and Technology","doi-asserted-by":"publisher","award":["DST\/INT\/BLR\/P-33\/2023(G)"],"award-info":[{"award-number":["DST\/INT\/BLR\/P-33\/2023(G)"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbagen.2026.130903","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:22:26Z","timestamp":1768004546000},"page":"130903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dendrimer-based therapeutics in neurological disorders: Innovations and clinical prospects"],"prefix":"10.1016","volume":"1870","author":[{"given":"Karthikeya Lalitha Siddhartha","family":"Pallem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Aswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2026.130903_bb0005","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8844030","article-title":"Dendrimers: a new race of pharmaceutical nanocarriers","volume":"2021","author":"Mittal","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.bbagen.2026.130903_bb0010","series-title":"Cascade\u2019- and \u2018Nonskid-Chain-like\u2019 Syntheses of Molecular Cavity Topologies","first-page":"155","volume":"02","author":"Buhleier","year":"1978"},{"issue":"11","key":"10.1016\/j.bbagen.2026.130903_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules23112849","article-title":"New advances in general biomedical applications of PAMAM dendrimers","volume":"23","author":"de Ara\u00fajo","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bbagen.2026.130903_bb0020","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.2147\/IJN.S243155","article-title":"PAMAM dendrimer nanomolecules utilized as drug delivery systems for potential treatment of glioblastoma: a systematic review","volume":"15","author":"Fana","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bbagen.2026.130903_bb0025","first-page":"2042","article-title":"Dendrimers: polymerization and properties","volume":"1, no. c","author":"Gorman","year":"2001","journal-title":"Encycl. Mater. Sci. Technol."},{"issue":"10","key":"10.1016\/j.bbagen.2026.130903_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules22101581","article-title":"Function oriented molecular design: dendrimers as novel antimicrobials","volume":"22","author":"Garc\u00eda-Gallego","year":"2017","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.bbagen.2026.130903_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15072013","article-title":"The spicy science of dendrimers in the realm of Cancer nanomedicine: a report from the COST action CA17140 Nano2Clinic","volume":"15","author":"Pricl","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbagen.2026.130903_bb0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1295\/polymj.17.117","article-title":"A new class of polymers: starburst-dendritic","volume":"17, no. I","author":"Tomalia","year":"1985","journal-title":"Polym. J."},{"issue":"8","key":"10.1016\/j.bbagen.2026.130903_bb0045","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1359-6446(01)01757-3","article-title":"Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications","volume":"6","author":"Esfand","year":"2001","journal-title":"Drug Discov. Today"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130903_bb0050","first-page":"434","article-title":"PAMAM dendrimers - diverse biomedical applications. Facts and unresolved questions","volume":"4","author":"Labieniec","year":"2009","journal-title":"Cent. Eur. J. Biol."},{"issue":"1\u20132","key":"10.1016\/j.bbagen.2026.130903_bb0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpharm.2015.04.036","article-title":"Singly and binary grafted poly(vinyl chloride) urinary catheters that elute ciprofloxacin and prevent bacteria adhesion","volume":"488","author":"Islas","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbagen.2026.130903_bb0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-1978-24702","article-title":"\u2018Cascade\u2019- and \u2018nonskid-Chain-like\u2019 syntheses of molecular cavity topologies","volume":"2","author":"Buhleier","year":"1978","journal-title":"Synthesis (Stuttg)."},{"issue":"9","key":"10.1016\/j.bbagen.2026.130903_bb0065","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/anie.199313081","article-title":"Poly(propylene imine) dendrimers: large-scale synthesis by Hetereogeneously catalyzed hydrogenations","volume":"32","author":"de Brabander-van den Berg","year":"1993","journal-title":"Angew. Chemie Int. Ed. English"},{"key":"10.1016\/j.bbagen.2026.130903_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.matchemphys.2020.122641","article-title":"Poly (propylene imine) dendrimer: a potential nanomaterial for electrochemical application","volume":"244","author":"Idris","year":"2020","journal-title":"Mater. Chem. Phys."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130903_bb0075","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.progpolymsci.2013.07.005","article-title":"Dendrimer as nanocarrier for drug delivery","volume":"39","author":"Kesharwani","year":"2014","journal-title":"Prog. Polym. Sci."},{"issue":"13","key":"10.1016\/j.bbagen.2026.130903_bb0080","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.2174\/1568026616666161222104112","article-title":"Chemical structure and surface modification of dendritic nanomaterials tailored for therapeutic and diagnostic applications","volume":"17","author":"Myung","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbagen.2026.130903_bb0085","series-title":"United States Patent (19)","author":"Denkewalter","year":"1981"},{"issue":"3\u20134","key":"10.1016\/j.bbagen.2026.130903_bb0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1389-0352(01)00061-7","article-title":"Peptide dendrimers: applications and synthesis","volume":"90","author":"Sadler","year":"2002","journal-title":"Rev. Mol. Biotechnol."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130903_bb0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1295\/polymj.17.117","article-title":"A new class of polymers: starburst-dendritic macromolecules","volume":"17","author":"Tomalia","year":"1985","journal-title":"Polym. J."},{"issue":"March","key":"10.1016\/j.bbagen.2026.130903_bb0100","first-page":"1","article-title":"Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment","volume":"14","author":"Kaurav","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130903_bb0105","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1021\/nn305860k","article-title":"Cationic poly- L -lysine dendrimer complexes doxorubicin and delays tumor growth in vitro and in vivo","volume":"7","author":"Al-Jamal","year":"2013","journal-title":"ACS Nano"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130903_bb0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejps.2009.07.008","article-title":"Dendrimers: Emerging polymers for drug-delivery systems","volume":"38","author":"Nanjwade","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"issue":"3\u20134","key":"10.1016\/j.bbagen.2026.130903_bb0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1389-0352(01)00062-9","article-title":"Design and synthesis of glycodendrimers","volume":"90","author":"Turnbull","year":"2002","journal-title":"Rev. Mol. Biotechnol."},{"key":"10.1016\/j.bbagen.2026.130903_bb0120","article-title":"Carbosilane dendrimers: drug and gene delivery applications","volume":"59","author":"Rabiee","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bbagen.2026.130903_bb0125","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1039\/c39900001084","article-title":"Phosphonium cascade molecules","volume":"16","author":"Rengan","year":"1990","journal-title":"J. Chem. Soc. Chem. Commun."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130903_bb0130","first-page":"1","article-title":"Insights into interactions between interleukin-6 and dendritic polyglycerols","volume":"22","author":"Mar\u0161i\u0107","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"February","key":"10.1016\/j.bbagen.2026.130903_bb0135","article-title":"Journal of drug delivery science and technology dendrimers in the context of targeting central nervous system disorders","volume":"73","author":"Palan","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"December 2024","key":"10.1016\/j.bbagen.2026.130903_bb0140","article-title":"Nano trends engineering PAMAM dendrimers for optimized drug delivery","volume":"9","author":"Aleebrahim","year":"2025","journal-title":"Nano Trends"},{"issue":"October 2019","key":"10.1016\/j.bbagen.2026.130903_bb0145","article-title":"Dendrimers in the context of nanomedicine","volume":"573","author":"Dias","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130903_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.preme.2025.100037","article-title":"Surface engineering of nanoparticles for precision medicine","volume":"2","author":"Zheng","year":"2025","journal-title":"Precis. Med. Eng."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130903_bb0155","doi-asserted-by":"crossref","DOI":"10.1007\/s11051-021-05175-8","article-title":"Advances in dendrimer-mediated targeted drug delivery to the brain","volume":"23","author":"Gauro","year":"2021","journal-title":"J. Nanopart. Res."},{"issue":"12","key":"10.1016\/j.bbagen.2026.130903_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom9120790","article-title":"Dendrimer-based drug delivery systems for brain targeting","volume":"9","author":"Zhu","year":"2019","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130903_bb0165","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/cn400182z","article-title":"Dendrimer advances for the central nervous system delivery of therapeutics","volume":"5","author":"Xu","year":"2014","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.bbagen.2026.130903_bb0170","series-title":"Dendrimers for Diagnostic Applications","author":"Rai","year":"2019"},{"issue":"December 2024","key":"10.1016\/j.bbagen.2026.130903_bb0175","article-title":"Mechanisms of receptor-mediated transcytosis at the blood-brain barrier","volume":"381","author":"Baghirov","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bbagen.2026.130903_bb0180","series-title":"Activated Microglia Targeting Dendrimer \u2212 Minocycline Conjugate as Therapeutics for Neuroin fl ammation","first-page":"2874","author":"Kannan","year":"2017"},{"key":"10.1016\/j.bbagen.2026.130903_bb0185","article-title":"Advances in redox research advancements in mitochondrial-targeted antioxidants: organelle-specific drug delivery for disease management","volume":"17, no. August","author":"Nahar","year":"2025","journal-title":"Adv. Redox Res."},{"key":"10.1016\/j.bbagen.2026.130903_bb0190","series-title":"Dendrimers and Derivatives as Multifunctional Nanotherapeutics for Alzheimer\u2019 S Disease","author":"Moreira","year":"2023"},{"issue":"10","key":"10.1016\/j.bbagen.2026.130903_bb0195","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1021\/acs.molpharmaceut.6b00381","article-title":"Mechanism of PAMAM dendrimers internalization in hippocampal neurons","volume":"13","author":"Vidal","year":"2016","journal-title":"Mol. Pharm."},{"issue":"19","key":"10.1016\/j.bbagen.2026.130903_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules25194489","article-title":"Dendrimers as modulators of brain cells","volume":"25","author":"Maysinger","year":"2020","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.bbagen.2026.130903_bb0205","first-page":"1","article-title":"Methodology used in the study","volume":"7","author":"Poojar","year":"2017","journal-title":"Asian J. Pharm. Clin. Res."},{"issue":"9","key":"10.1016\/j.bbagen.2026.130903_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules23092238","article-title":"Use of polyamidoamine dendrimers in brain diseases","volume":"23","author":"Florendo","year":"2018","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130903_bb0215","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7150\/ntno.38954","article-title":"Research paper enhanced blood-brain-barrier penetrability and tumor-targeting efficiency by peptide-functionalized poly(Amidoamine) dendrimer for the therapy of gliomas","volume":"3","author":"Liu","year":"2019","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.bbagen.2026.130903_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105439","article-title":"Celecoxib substituted biotinylated poly(amidoamine) G3 dendrimer as potential treatment for temozolomide resistant glioma therapy and anti-nematode agent","volume":"152","author":"Uram","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.bbagen.2026.130903_bb0225","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/joim.12280","article-title":"Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications","volume":"276","author":"Kannan","year":"2014","journal-title":"J. Intern. Med."},{"issue":"130","key":"10.1016\/j.bbagen.2026.130903_bb0230","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003162","article-title":"Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model","volume":"4","author":"Kannan","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"15","key":"10.1016\/j.bbagen.2026.130903_bb0235","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/j.addr.2005.09.018","article-title":"Dendrimers in biomedical applications - reflections on the field","volume":"57","author":"Svenson","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"26","key":"10.1016\/j.bbagen.2026.130903_bb0240","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1039\/C4TB00171K","article-title":"Dendrimers for drug delivery","volume":"2","author":"Caminade","year":"2014","journal-title":"J. Mater. Chem. B"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130903_bb0245","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q","article-title":"Preliminary biological evaluation of polyamidoamine (PAMAM) starburst\u2122 dendrimers","volume":"30","author":"Roberts","year":"1996","journal-title":"J. Biomed. Mater. Res."},{"issue":"1\u20132","key":"10.1016\/j.bbagen.2026.130903_bb0250","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0378-5173(03)00225-4","article-title":"Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers","volume":"259","author":"Kolhe","year":"2003","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.bbagen.2026.130903_bb0255","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.addr.2013.01.001","article-title":"Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview","volume":"65","author":"Mignani","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1\u20132","key":"10.1016\/j.bbagen.2026.130903_bb0260","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2010.04.027","article-title":"Dendrimer toxicity: let\u2019s meet the challenge","volume":"394","author":"Jain","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130903_bb0265","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.drudis.2014.12.012","article-title":"Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery","volume":"20","author":"Kesharwani","year":"2015","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130903_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-017-1004-5","article-title":"Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome","volume":"14","author":"Nance","year":"2017","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130903_bb0275","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejpb.2008.09.026","article-title":"Multifunctional and stimuli-sensitive pharmaceutical nanocarriers","volume":"71","author":"Torchilin","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bbagen.2026.130903_bb0280","series-title":"Dendrimers: Synthesis, Applications, and Properties","first-page":"1","author":"Abbasi","year":"2014"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130903_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23040938","article-title":"Dendrimers for drug delivery","volume":"23","author":"Chauhan","year":"2018","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130903_bb0290","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1039\/C7CS00550D","article-title":"Dendrimers in combination with natural products and analogues as anti-cancer agents","volume":"47","author":"Mignani","year":"2018","journal-title":"Chem. Soc. Rev."},{"issue":"5\u20136","key":"10.1016\/j.bbagen.2026.130903_bb0295","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.drudis.2010.01.009","article-title":"Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications","volume":"15","author":"Menjoge","year":"2010","journal-title":"Drug Discov. Today"},{"issue":"8","key":"10.1016\/j.bbagen.2026.130903_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/biom9080330","article-title":"Cytotoxicity of dendrimers","volume":"9","author":"Janaszewska","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbagen.2026.130903_bb0305","series-title":"Toxicity and Biocompatibility Aspects of Dendrimers","author":"Gothwal","year":"2019"},{"key":"10.1016\/j.bbagen.2026.130903_bb0310","series-title":"The Role of Nanomedicine and Artificial Intelligence in cancer Health Care: Individual Applications and Emerging Integrations\u2014A Narrative Review","volume":"vol. 16, no. 1","author":"Samathoti","year":"2025"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130903_bb0315","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.apsb.2014.03.001","article-title":"Brain tumor-targeted drug delivery strategies","volume":"4","author":"Wei","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"issue":"1\u20132","key":"10.1016\/j.bbagen.2026.130903_bb0320","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijpharm.2013.01.057","article-title":"Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma","volume":"445","author":"Bai","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.bbagen.2026.130903_bb0325","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3892\/or.2013.2283","article-title":"Poly(amido amine) is an ideal carrier of miR-7 for enhancing gene silencing effects on the EGFR pathway in U251 glioma cells","volume":"29","author":"Liu","year":"2013","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbagen.2026.130903_bb0330","first-page":"821","article-title":"Nonviral gene therapy in vivo with PAM-RG4\/ apoptin as a potential brain tumor therapeutic","volume":"8","author":"An","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"28","key":"10.1016\/j.bbagen.2026.130903_bb0335","doi-asserted-by":"crossref","first-page":"43095","DOI":"10.18632\/oncotarget.9355","article-title":"PDTargeting glioma stem cells enhances anti-tumor effect of boron neutron capture therapy","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130903_bb0340","first-page":"629","article-title":"SRL-coated PAMAM dendrimer nano-carrier for targeted gene delivery to the glioma cells and competitive inhibition by lactoferrin","volume":"15","author":"Zarebkohan","year":"2016","journal-title":"Iran. J. Pharm. Res."},{"issue":"1\u20132","key":"10.1016\/j.bbagen.2026.130903_bb0345","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijpharm.2016.09.083","article-title":"Dipeptide-functionalized polyamidoamine dendrimer-mediated apoptin gene delivery facilitates apoptosis of human primary glioma cells","volume":"515","author":"Bae","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.bbagen.2026.130903_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105691","article-title":"In vitro validation of the therapeutic potential of dendrimer-based Nanoformulations against tumor stem cells","volume":"23","author":"Knauer","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.bbagen.2026.130903_bb0355","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ijpharm.2012.10.024","article-title":"Delivery of paclitaxel across cellular barriers using a dendrimer-based nanocarrier","volume":"441","author":"Teow","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbagen.2026.130903_bb0360","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jcis.2016.07.047","article-title":"Ligand anchored poly(propyleneimine) dendrimers for brain targeting: comparative in vitro and in vivo assessment","volume":"482","author":"Patel","year":"2016","journal-title":"J. Colloid Interface Sci."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130903_bb0365","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/1061186X.2017.1344849","article-title":"A novel synergetic targeting strategy for glioma therapy employing borneol combination with angiopep-2-modified, DOX-loaded PAMAM dendrimer","volume":"26","author":"Han","year":"2018","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130903_bb0370","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-017-2324-y","article-title":"Chitosan engineered PAMAM dendrimers as Nanoconstructs for the enhanced anti-Cancer potential and improved in vivo brain pharmacokinetics of Temozolomide","volume":"35","author":"Sharma","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bbagen.2026.130903_bb0375","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.2147\/IJN.S175418","article-title":"A novel RGDyC\/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system","volume":"13","author":"Lu","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bbagen.2026.130903_bb0380","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijpharm.2018.11.035","article-title":"\u2018Dendrimer-Cationized-albumin\u2019 encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin","volume":"555","author":"Muniswamy","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"9","key":"10.1016\/j.bbagen.2026.130903_bb0385","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1021\/acs.biomac.0c01033","article-title":"Targeting mitochondria in tumor-associated macrophages using a dendrimer-conjugated TSPO ligand that stimulates antitumor signaling in glioblastoma","volume":"21","author":"Sharma","year":"2020","journal-title":"Biomacromolecules"},{"issue":"12","key":"10.1016\/j.bbagen.2026.130903_bb0390","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1021\/acs.biomac.0c01270","article-title":"Dendrimer-mediated targeted delivery of rapamycin to tumor-associated macrophages improves systemic treatment of glioblastoma","volume":"21","author":"Sharma","year":"2020","journal-title":"Biomacromolecules"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130903_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mabi.202000392","article-title":"PMPC modified PAMAM dendrimer enhances brain tumor-targeted drug delivery","volume":"21","author":"Ban","year":"2021","journal-title":"Macromol. Biosci."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130903_bb0400","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s13346-021-01017-1","article-title":"Tailoring drug co-delivery nanosystem for mitigating U-87 stem cells drug resistance","volume":"12","author":"Behrooz","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"issue":"7","key":"10.1016\/j.bbagen.2026.130903_bb0405","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1021\/acsbiomaterials.3c00263","article-title":"Angiopep-2 grafted PAMAM dendrimers for the targeted delivery of temozolomide: in vitro and in vivo effects of PEGylation in the management of glioblastoma multiforme","volume":"9","author":"Sahoo","year":"2023","journal-title":"ACS Biomater Sci. Eng."},{"issue":"5","key":"10.1016\/j.bbagen.2026.130903_bb0410","doi-asserted-by":"crossref","DOI":"10.1007\/s11051-013-1621-6","article-title":"In vitro evaluation of the cytotoxicity and cellular uptake of CMCht\/PAMAM dendrimer nanoparticles by glioblastoma cell models","volume":"15","author":"Pojo","year":"2013","journal-title":"J. Nanopart. Res."},{"key":"10.1016\/j.bbagen.2026.130903_bb0415","first-page":"1","article-title":"Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimer","volume":"10","author":"Gao","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130903_bb0420","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.biomaterials.2015.02.053","article-title":"Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers","volume":"52","author":"Zhang","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbagen.2026.130903_bb0425","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jcis.2015.03.019","article-title":"CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery","volume":"450","author":"Zhao","year":"2015","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bbagen.2026.130903_bb0430","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.colsurfb.2016.08.002","article-title":"PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma","volume":"147","author":"Jiang","year":"2016","journal-title":"Colloids Surfaces B Biointerfaces"},{"issue":"9","key":"10.1016\/j.bbagen.2026.130903_bb0435","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.1021\/acs.nanolett.8b01879","article-title":"Peptide-functionalized Nanoinhibitor restrains brain tumor growth by abrogating mesenchymal-epithelial transition factor (MET) signaling","volume":"18","author":"Wu","year":"2018","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130903_bb0440","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbrc.2020.04.064","article-title":"iRGD and TGN co-modified PAMAM for multi-targeted delivery of ATO to gliomas","volume":"527","author":"Shi","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.bbagen.2026.130903_bb0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom12081116","article-title":"Design, synthesis and activity of new N1-alkyl tryptophan functionalized Dendrimeric peptides against glioblastoma","volume":"12","author":"Sowi\u0144ska","year":"2022","journal-title":"Biomolecules"},{"issue":"24","key":"10.1016\/j.bbagen.2026.130903_bb0450","doi-asserted-by":"crossref","first-page":"6534","DOI":"10.1016\/j.biomaterials.2014.04.057","article-title":"Gadolinium-functionalized nanographene oxide for combined drug and microRNA delivery and magnetic resonance imaging","volume":"35","author":"Yang","year":"2014","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.bbagen.2026.130903_bb0455","article-title":"Targeted Theranostic approach for glioma using dendrimer-based curcumin nanoparticle","volume":"7","author":"Gamage","year":"2016","journal-title":"J. Nanomed. Nanotechnol."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130903_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/btm2.10160","article-title":"Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration","volume":"5","author":"Liaw","year":"2020","journal-title":"Bioeng. Transl. Med."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130903_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-023-01684-w","article-title":"miRNA-211 maintains metabolic homeostasis in medulloblastoma through its target gene long-chain acyl-CoA synthetase 4","volume":"11","author":"Yuan","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130903_bb0470","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/s40001-024-01915-3","article-title":"Alzheimer\u2019s disease and drug delivery across the blood-brain barrier: approaches and challenges","volume":"29","author":"Iqbal","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130903_bb0475","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2174\/0929867311302010013","article-title":"Molecular properties of lysine dendrimers and their interactions with a&beta;-peptides and neuronal cells","volume":"20","author":"Neelov","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbagen.2026.130903_bb0480","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.2174\/1389201019666180226152542","article-title":"A dual targeting drug delivery system for penetrating blood brain barrier and selectively delivering siRNA to neurons for Alzheimer\u2019s disease treatment","volume":"19","author":"Zhang","year":"2018","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.bbagen.2026.130903_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2018.04.032","article-title":"PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: a biophysical and Nanotoxicological characterization","author":"Igart\u00faa","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.bbagen.2026.130903_bb0490","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1021\/acs.molpharmaceut.8b00537","article-title":"Boosted memory and improved brain bioavailability of Rivastigmine: targeting effort to the brain using covalently tethered lower generation PAMAM dendrimers with Lactoferrin","volume":"15","author":"Gothwal","year":"2018","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbagen.2026.130903_bb0495","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1021\/acschemneuro.9b00286","article-title":"Behavioral and biochemical implications of Dendrimeric Rivastigmine in memory-deficit and Alzheimer \u2019 s induced rodents","volume":"10","author":"Gothwal","year":"2019","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.bbagen.2026.130903_bb0500","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1021\/acs.bioconjchem.9b00505","article-title":"Lactoferrin coupled lower generation PAMAM dendrimers for brain targeted delivery of Memantine in aluminum chloride induced Alzheimer \u2019 s disease in mice","volume":"30","author":"Gothwal","year":"2019","journal-title":"ACS Bioconj. Chem."},{"key":"10.1016\/j.bbagen.2026.130903_bb0505","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1021\/acsomega.8b03445","article-title":"Dendrimer donepezil conjugates for improved brain delivery and better in vivo pharmacokinetics","volume":"4","author":"Singh","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbagen.2026.130903_bb0510","series-title":"Dendrimeric Poly (Epsilon-Lysine) Delivery Systems for the Enhanced Permeability of Flurbiprofen across the Blood-Brain Barrier in Alzheimer \u2019 s Disease","first-page":"1","author":"Al-azzawi","year":"2025"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130903_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-020-01652-w","article-title":"Combined therapy for Alzheimer\u2019s disease: Tacrine and PAMAM dendrimers co-administration reduces the side effects of the drug without modifying its activity","volume":"21","author":"Igart\u00faa","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130903_bb0520","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1039\/D0NR05958G","article-title":"Dendrimer-tesaglitazar conjugate induces a phenotype shift of microglia and enhances \u03b2-amyloid phagocytosis","volume":"13","author":"Deridder","year":"2021","journal-title":"Nanoscale"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130903_bb0525","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1021\/acsnano.0c09159","article-title":"Liver X receptor activation with an intranasal polymer therapeutic prevents cognitive decline without altering lipid levels","volume":"15","author":"Navas Guimaraes","year":"2021","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.bbagen.2026.130903_bb0530","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-022-02393-8","article-title":"Fabrication of TPGS-grafted Polyamidoamine dendrimer for enhanced Piperine brain delivery and pharmacokinetics","volume":"23","author":"Singh","year":"2022","journal-title":"AAPS PharmSciTech"},{"issue":"10","key":"10.1016\/j.bbagen.2026.130903_bb0535","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102066","article-title":"Dendrimer-conjugated nSMase2 inhibitor reduces tau propagation in mice","volume":"14","author":"Tallon","year":"2022","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.bbagen.2026.130903_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15092364","article-title":"Microglial-targeted nSMase2 inhibitor fails to reduce tau propagation in PS19 mice","volume":"15","author":"Huang","year":"2023","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.bbagen.2026.130903_bb0545","doi-asserted-by":"crossref","first-page":"3570","DOI":"10.1021\/bm400948z","article-title":"Effect of poly(propylene imine) glycodendrimers on \u03b2-amyloid aggregation in vitro and in APP\/PS1 transgenic mice, as a model of brain amyloid deposition and alzheimer\u2019s disease","volume":"14","author":"Klementieva","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bbagen.2026.130903_bb0550","series-title":"Biological and Environmental Phenomena at the Interface Hydrophobic Modification of Carboxyl-Terminated PAMAM Dendrimer Surface Creates a Potent Inhibitor of Amyloid- # Fibrillation Dendrimer Surface Creates a Potent Inhibitor of Amyloid-\u03b2 Fibrillation","author":"Wang","year":"2018"},{"key":"10.1016\/j.bbagen.2026.130903_bb0555","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.nano.2019.01.010","article-title":"Poly (propylene imine) dendrimers with histidine-maltose shell as novel type of nanoparticles for synapse and memory protection","volume":"17","author":"Aso","year":"2019","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.bbagen.2026.130903_bb0560","series-title":"Mixed Carboxyl and Hydrophobic Dendrimer Surface Inhibits Amyloid - \u03b2 Fibrillation: New Insight from the Generation Number E Ff Ect","author":"Wang","year":"2019"},{"issue":"50","key":"10.1016\/j.bbagen.2026.130903_bb0565","doi-asserted-by":"crossref","first-page":"59673","DOI":"10.1021\/acsami.1c17823","article-title":"Functional Gallic acid-based dendrimers as synthetic Nanotools to remodel amyloid-\u03b2-42 into noncytotoxic forms","volume":"13","author":"Ara\u00fajo","year":"2021","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130903_bb0570","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1021\/acschemneuro.7b00301","article-title":"Dendritic polyglycerol sulfates in the prevention of synaptic loss and mechanism of action on glia","volume":"9","author":"Maysinger","year":"2018","journal-title":"ACS Chem. Nerosci."},{"issue":"26","key":"10.1016\/j.bbagen.2026.130903_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adma.202100746","article-title":"Biomimetic dendrimer\u2013peptide conjugates for early multi-target therapy of alzheimer\u2019s disease by inflammatory microenvironment modulation","volume":"33","author":"Liu","year":"2021","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130903_bb0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-96379-4","article-title":"In situ identification and G4-PPI-his-mal-dendrimer-induced reduction of early-stage amyloid aggregates in Alzheimer\u2019s disease transgenic mice using synchrotron-based infrared imaging","volume":"11","author":"Benseny-Cases","year":"2021","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130903_bb0585","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adhm.202101854","article-title":"Reversing a\u03b2 fibrillation and inhibiting a\u03b2 primary neuronal cell toxicity using amphiphilic Polyphenylene Dendrons","volume":"11","author":"Xiang","year":"2022","journal-title":"Adv. Healthc. Mater."},{"issue":"8","key":"10.1016\/j.bbagen.2026.130903_bb0590","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084391","article-title":"Engineered neutral phosphorous dendrimers protect mouse cortical neurons and brain organoids from Excitotoxic death","volume":"23","author":"Posadas","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"42","key":"10.1016\/j.bbagen.2026.130903_bb0595","doi-asserted-by":"crossref","first-page":"47445","DOI":"10.1021\/acsami.2c14220","article-title":"Nanostars carrying multifunctional neurotrophic dendrimers protect neurons in preclinical in vitro models of neurodegenerative disorders","volume":"14","author":"Morfill","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130903_bb0600","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1021\/bm501244m","article-title":"Urea and thiourea modified polypropyleneimine dendrimers clear intracellular \u03b1-synuclein aggregates in a human cell line","volume":"16","author":"Laumann","year":"2015","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130903_bb0605","first-page":"139","article-title":"\u4e73\u9f20\u5fc3\u808c\u63d0\u53d6 HHS public access","volume":"176","author":"Gloria","year":"2018","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.bbagen.2026.130903_bb0610","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0090393","article-title":"Optimization and in vivo toxicity evaluation of g4.5 pamam dendrimer-risperidone complexes","volume":"9","author":"Prieto","year":"2014","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.bbagen.2026.130903_bb0615","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1021\/acs.molpharmaceut.5b00402","article-title":"Brain targeting of a water insoluble antipsychotic drug haloperidol via the intranasal route using PAMAM dendrimer","volume":"12","author":"Katare","year":"2015","journal-title":"Mol. Pharm."},{"issue":"August","key":"10.1016\/j.bbagen.2026.130903_bb0620","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejpb.2020.09.001","article-title":"Surface-engineered nanoliposomes with lipidated and non-lipidated peptide-dendrimeric scaffold for efficient transdermal delivery of a therapeutic agent: development, characterization, toxicological and preclinical performance analyses","volume":"156","author":"Manikkath","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bbagen.2026.130903_bb0625","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2020.04.036","article-title":"Dendrimer mediated targeted delivery of sinomenine for the treatment of acute neuroinflammation in traumatic brain injury","volume":"323","author":"Sharma","year":"2020","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.bbagen.2026.130903_bb0630","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.nano.2014.03.008","article-title":"Fetal uptake of intra-amniotically delivered dendrimers in a mouse model of intrauterine inflammation and preterm birth","volume":"10","author":"Burd","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1\u20132","key":"10.1016\/j.bbagen.2026.130903_bb0635","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2018.04.040","article-title":"Pediatric oral formulation of dendrimer-N-acetyl-L-cysteine conjugates for the treatment of neuroinflammation","volume":"545","author":"Yellepeddi","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.bbagen.2026.130903_bb0640","first-page":"139","article-title":"\u4e73\u9f20\u5fc3\u808c\u63d0\u53d6 HHS public access","volume":"176","author":"Anandita","year":"2016","journal-title":"Arter. Thromb Vasc Biol"},{"issue":"October","key":"10.1016\/j.bbagen.2026.130903_bb0645","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jconrel.2020.10.064","article-title":"Brain gene delivery using histidine and arginine-modified dendrimers for ischemic stroke therapy","volume":"330","author":"Lee","year":"2021","journal-title":"J. Control. Release"},{"issue":"July 2020","key":"10.1016\/j.bbagen.2026.130903_bb0650","article-title":"Neuroprotective effects of a dendrimer-based glutamate carboxypeptidase inhibitor on superoxide dismutase transgenic mice after neonatal hypoxic-ischemic brain injury","volume":"148","author":"Arteaga Cabeza","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.bbagen.2026.130903_bb0655","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1021\/nn404872e","article-title":"Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest","volume":"8","author":"Mishra","year":"2014","journal-title":"ACS Nano"},{"issue":"7","key":"10.1016\/j.bbagen.2026.130903_bb0660","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/mabi.201500058","article-title":"Dexamethasone-conjugated Polyamidoamine dendrimer for delivery of the Heme Oxygenase-1 Gene into the ischemic brain","volume":"15","author":"Jeon","year":"2015","journal-title":"Macromol. Biosci."},{"issue":"August","key":"10.1016\/j.bbagen.2026.130903_bb0665","article-title":"Dendrimer grafted albumin nanoparticles for the treatment of post cerebral stroke damages: a proof of concept study","volume":"184","author":"Pradhan","year":"2019","journal-title":"Colloids Surfaces B Biointerfaces"},{"issue":"3","key":"10.1016\/j.bbagen.2026.130903_bb0670","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1039\/C8RA06688D","article-title":"Neutrophil-mediated and low density lipoprotein receptor-mediated dual-targeting nanoformulation enhances brain accumulation of scutellarin and exerts neuroprotective effects against ischemic stroke","volume":"9","author":"Dang","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbagen.2026.130903_bb0675","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jconrel.2016.06.046","article-title":"Surface functionality affects the biodistribution and microglia-targeting of intra-amniotically delivered dendrimers","volume":"237","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.bbagen.2026.130903_bb0680","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/mabi.201500268","article-title":"Disruption of amyloid prion protein aggregates by cationic Pyridylphenylene dendrimers","volume":"16","author":"Sorokina","year":"2016","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.bbagen.2026.130903_bb0685","series-title":"Theranostics Direct Macromolecular Drug Delivery to Cerebral Ischemia Area using Neutrophil-Mediated Nanoparticles","volume":"7(13)","author":"Zhang","year":"2017"},{"issue":"September","key":"10.1016\/j.bbagen.2026.130903_bb0690","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jconrel.2018.10.006","article-title":"PAMAM dendrimers: blood-brain barrier transport and neuronal uptake after focal brain ischemia","volume":"291","author":"Santos","year":"2018","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.bbagen.2026.130903_bb0695","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1021\/acs.biomac.9b00494","article-title":"Label-free fluorescent poly(amidoamine) dendrimer for traceable and controlled drug delivery","volume":"20","author":"Wang","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bbagen.2026.130903_bb0700","series-title":"Validation of Poly (Propylene Imine) Glycodendrimers Towards their Anti-Prion Conversion Efficiency","author":"Schmitz","year":"2019"},{"issue":"12","key":"10.1016\/j.bbagen.2026.130903_bb0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/brb3.2810","article-title":"Preparation of gastrodin-modified dendrimer-entrapped gold nanoparticles as a drug delivery system for cerebral ischemia\u2013reperfusion injury","volume":"12","author":"Huang","year":"2022","journal-title":"Brain Behav."},{"key":"10.1016\/j.bbagen.2026.130903_bb0710","article-title":"Machine learning empowered formulation design, optimization and characterization of nanoparticulate drug delivery systems: current applications, challenges, and future perspectives","volume":"no. xxx","author":"Shen","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bbagen.2026.130903_bb0715","series-title":"Artificial Intelligence-Enabled Nanomedicine: Enhancing Drug Design and Predictive Modeling in Pharmaceutics","first-page":"1","volume":"no. July","author":"Sar","year":"2025"},{"key":"10.1016\/j.bbagen.2026.130903_bb0720","series-title":"RSC Advances Nano-QSAR Modeling for Predicting Biological Activity of Diverse Nanomaterials \u2020","first-page":"13215","author":"Singh","year":"2014"},{"issue":"November 2025","key":"10.1016\/j.bbagen.2026.130903_bb0725","article-title":"Next Nanotechnology Bioinformatics models in drug delivery\u00a0: Predicting biomaterial-biological interactions for targeted therapies","volume":"9","author":"Singh","year":"2026","journal-title":"Next Nanotechnol."},{"key":"10.1016\/j.bbagen.2026.130903_bb0730","series-title":"Artificial Intelligence (AI) Applications in Drug Discovery and Drug Delivery: Revolutionizing Personalized Medicine","author":"Serrano","year":"2024"},{"key":"10.1016\/j.bbagen.2026.130903_bb0735","series-title":"Review of Current Achievements in Dendrimers and Nanomaterials for Potential Detection and Remediation of Chemical, Biological, Radiological and Nuclear Contamination - Integration with Artificial Intelligence and Remote Sensing Technologies","author":"Gonciarz","year":"2025"},{"key":"10.1016\/j.bbagen.2026.130903_bb0740","article-title":"Advances in brain - targeted delivery strategies and natural product - mediated enhancement of blood \u2013 brain barrier permeability","author":"Liu","year":"2025","journal-title":"BioMed. Central"},{"issue":"1","key":"10.1016\/j.bbagen.2026.130903_bb0745","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/17435390.2023.2186279","article-title":"Predicting the toxicity of nanoparticles using artificial intelligence tools: a systematic review","volume":"17","author":"Yazdipour","year":"2023","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.bbagen.2026.130903_bb0750","series-title":"Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design","author":"Vora","year":"2023"},{"issue":"August 2019","key":"10.1016\/j.bbagen.2026.130903_bb0755","article-title":"Dendrimers in the context of nanomedicine","volume":"573","author":"Dias","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bbagen.2026.130903_bb0760","series-title":"Dendrimers toward Translational Nanotherapeutics: Concise Key Step Analysis","author":"Cen","year":"2020"},{"key":"10.1016\/j.bbagen.2026.130903_bb0765","series-title":"Nanoscale Dendrimer-based Nanocarriers for Central Nervous","first-page":"23202","author":"Bharadwaj","year":"2025"},{"issue":"July","key":"10.1016\/j.bbagen.2026.130903_bb0770","first-page":"1","article-title":"Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial","volume":"2652","author":"Gusdon","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbagen.2026.130903_bb0775","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/IJO.IJO_1120_24","article-title":"Review article dry and neovascular \u2018 wet \u2019 age - related macular degeneration: upcoming therapies wet macular degeneration - upcoming therapy","author":"Yan","year":"2025","journal-title":"Ind. J. Ophthalmol."},{"key":"10.1016\/j.bbagen.2026.130903_bb0780","series-title":"Clinical Radiosynthesis and Translation of [ 18 F ] OP-801: A Novel Radiotracer for Imaging Reactive Microglia and Macrophages","author":"Jackson","year":"2023"},{"key":"10.1016\/j.bbagen.2026.130903_bb0785","series-title":"Starpharma Commences Dendrimer-Docetaxel Clinical Trial","first-page":"1","volume":"no. January","author":"Executive","year":"2014"},{"key":"10.1016\/j.bbagen.2026.130903_bb0790","doi-asserted-by":"crossref","first-page":"S1186","DOI":"10.1016\/j.annonc.2022.07.1889","article-title":"1403P efficacy and safety of dendrimer-enhanced (DEP) cabazitaxel (CTX-SPL9111) in men with metastatic castration-resistant prostate cancer (mCRPC) in a phase I\/II trial","volume":"33","author":"Jones","year":"2022","journal-title":"Ann. Oncol."},{"issue":"26","key":"10.1016\/j.bbagen.2026.130903_bb0795","first-page":"2918","article-title":"Dendrimer-nanoparticle (DEP) delivery of topoisomerase I inhibitor, SN38 (DEP-SN38): safety, tolerability, and preliminary efficacy study in patients with advanced solid tumors","volume":"43","author":"Liu","year":"2025","journal-title":"J. Clin. Oncol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T09:31:51Z","timestamp":1770715911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416526000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":159,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0304416526000036"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130903","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendrimer-based therapeutics in neurological disorders: Innovations and clinical prospects","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130903"}}